{"id":23697,"date":"2022-12-12T16:26:00","date_gmt":"2022-12-12T08:26:00","guid":{"rendered":"https:\/\/flcube.com\/?p=23697"},"modified":"2025-01-28T16:33:21","modified_gmt":"2025-01-28T08:33:21","slug":"sequanta-technologies-and-iomics-bio-collaborate-on-multi-omics-research","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=23697","title":{"rendered":"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research"},"content":{"rendered":"\n<p>Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences Co., Ltd, a gene sequencing and diagnostic equipment developer based in Beijing, have put pen to paper on an in-depth collaboration. The two will integrate respective technologies and capabilities to set up a joint laboratory in Beijing, alongside an integrated service and supply chain covering Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, and Shandong. In addition, the two firms plan to leverage respective advantages in genomics, ultra-sensitive proteomics, single cell space multi-omics joint detection and analysis, and high-throughput transcriptome sequencing for drug screening and research, to develop and apply high-throughput multi-omics detection and analysis technology to support drug translation, development, and clinical research. No financial details were disclosed.<\/p>\n\n\n\n<p><strong>Sequanta Technologies&#8217; Services<\/strong><br>Sequanta Technologies, focused on genomics, proteomics, and related services to support pharmaceutical clients in biomarker discovery and clinical trials, boasts a multi-omics analysis service platform, allowing for full-process services ranging from preclinical biomarker exploration to post-marketing research.<\/p>\n\n\n\n<p><strong>Iomics Bio&#8217;s Technology Platforms<\/strong><br>Iomics Bio, meanwhile, is focused on the brain science and tumor sectors, and boasts technology platforms such as those for ultrasensitive protein detection, high-throughput transcriptome, and spatial proteome.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,6],"tags":[30,3367,1013],"class_list":["post-23697","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","category-rd","tag-biotech","tag-iomics-biosciences","tag-sequanta-technologies"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences Co., Ltd, a gene sequencing and diagnostic equipment developer based in Beijing, have put pen to paper on an in-depth collaboration. The two will integrate respective technologies and capabilities to set up a joint laboratory in Beijing, alongside an integrated service and supply chain covering Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, and Shandong. In addition, the two firms plan to leverage respective advantages in genomics, ultra-sensitive proteomics, single cell space multi-omics joint detection and analysis, and high-throughput transcriptome sequencing for drug screening and research, to develop and apply high-throughput multi-omics detection and analysis technology to support drug translation, development, and clinical research. No financial details were disclosed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=23697\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research\" \/>\n<meta property=\"og:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=23697\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T08:26:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-28T08:33:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=23697#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=23697\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research\",\"datePublished\":\"2022-12-12T08:26:00+00:00\",\"dateModified\":\"2025-01-28T08:33:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=23697\"},\"wordCount\":208,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Biotech\",\"Iomics Biosciences\",\"Sequanta Technologies\"],\"articleSection\":[\"Company\",\"Deals\",\"R&amp;D\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=23697#respond\"]}],\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=23697\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=23697\",\"name\":\"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2022-12-12T08:26:00+00:00\",\"dateModified\":\"2025-01-28T08:33:21+00:00\",\"description\":\"Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences Co., Ltd, a gene sequencing and diagnostic equipment developer based in Beijing, have put pen to paper on an in-depth collaboration. The two will integrate respective technologies and capabilities to set up a joint laboratory in Beijing, alongside an integrated service and supply chain covering Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, and Shandong. In addition, the two firms plan to leverage respective advantages in genomics, ultra-sensitive proteomics, single cell space multi-omics joint detection and analysis, and high-throughput transcriptome sequencing for drug screening and research, to develop and apply high-throughput multi-omics detection and analysis technology to support drug translation, development, and clinical research. No financial details were disclosed.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=23697#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=23697\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=23697#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research - Insight, China&#039;s Pharmaceutical Industry","description":"Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences Co., Ltd, a gene sequencing and diagnostic equipment developer based in Beijing, have put pen to paper on an in-depth collaboration. The two will integrate respective technologies and capabilities to set up a joint laboratory in Beijing, alongside an integrated service and supply chain covering Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, and Shandong. In addition, the two firms plan to leverage respective advantages in genomics, ultra-sensitive proteomics, single cell space multi-omics joint detection and analysis, and high-throughput transcriptome sequencing for drug screening and research, to develop and apply high-throughput multi-omics detection and analysis technology to support drug translation, development, and clinical research. No financial details were disclosed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=23697","og_locale":"en_US","og_type":"article","og_title":"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research","og_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","og_url":"https:\/\/flcube.com\/?p=23697","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2022-12-12T08:26:00+00:00","article_modified_time":"2025-01-28T08:33:21+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=23697#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=23697"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research","datePublished":"2022-12-12T08:26:00+00:00","dateModified":"2025-01-28T08:33:21+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=23697"},"wordCount":208,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Biotech","Iomics Biosciences","Sequanta Technologies"],"articleSection":["Company","Deals","R&amp;D"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=23697#respond"]}],"copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=23697","url":"https:\/\/flcube.com\/?p=23697","name":"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2022-12-12T08:26:00+00:00","dateModified":"2025-01-28T08:33:21+00:00","description":"Sequanta Technologies, a multi-omics research and clinical service provider based in Shanghai, and Iomics Biosciences Co., Ltd, a gene sequencing and diagnostic equipment developer based in Beijing, have put pen to paper on an in-depth collaboration. The two will integrate respective technologies and capabilities to set up a joint laboratory in Beijing, alongside an integrated service and supply chain covering Beijing, Tianjin, Hebei, Shanxi, Inner Mongolia, and Shandong. In addition, the two firms plan to leverage respective advantages in genomics, ultra-sensitive proteomics, single cell space multi-omics joint detection and analysis, and high-throughput transcriptome sequencing for drug screening and research, to develop and apply high-throughput multi-omics detection and analysis technology to support drug translation, development, and clinical research. No financial details were disclosed.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=23697#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=23697"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=23697#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Sequanta Technologies and Iomics Bio Collaborate on Multi-Omics Research"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/23697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=23697"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/23697\/revisions"}],"predecessor-version":[{"id":23699,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/23697\/revisions\/23699"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=23697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=23697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=23697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}